U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07200245) titled 'Cardiovascular Complications After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors' on Sept. 10.
Brief Summary: Pheochromocytoma is an adrenomedullary chromaffin cell tumour that releases catecholamines. Adverse cardiovascular events are considered the main cause of morbidity and mortality in patients with pheochromocytoma. Consequently, preoperative medical preparations using alpha-blockers or other antihypertensive drugs and the control of hemodynamic instability during adrenalectomy for pheochromocytoma are recommended by guidelines to prevent vasoconstriction, perioperative cardiovascular complications, and the risk o...